Gauthier S - Search Results

1

Author response: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.

Gauthier S, Ng KP, Pascoal TA, Mathotaarachchi S, Chung CO, Benedetti AL, Shin M, Kang MS, Li X, Ba M, Kandiah N, Rosa-Neto P. Gauthier S, et al. Neurology. 2017 Oct 31;89(18):1931. doi: 10.1212/WNL.0000000000004593. Neurology. 2017. PMID: 29084927 No abstract available.

2

Prevalence of depression in Alzheimer's disease and validity of Research Diagnostic Criteria.

Vida S, Des Rosiers P, Carrier L, Gauthier S. Vida S, et al. Among authors: gauthier s. J Geriatr Psychiatry Neurol. 1994 Oct-Dec;7(4):238-44. doi: 10.1177/089198879400700409. J Geriatr Psychiatry Neurol. 1994. PMID: 7826494

3

Depression in Alzheimer's disease: receiver operating characteristic analysis of the Cornell Scale for Depression in Dementia and the Hamilton Depression Scale.

Vida S, Des Rosiers P, Carrier L, Gauthier S. Vida S, et al. Among authors: gauthier s. J Geriatr Psychiatry Neurol. 1994 Jul-Sep;7(3):159-62. doi: 10.1177/089198879400700306. J Geriatr Psychiatry Neurol. 1994. PMID: 7916939

4

Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies.

Nalbantoglu J, Gilfix BM, Bertrand P, Robitaille Y, Gauthier S, Rosenblatt DS, Poirier J. Nalbantoglu J, et al. Among authors: gauthier s. Ann Neurol. 1994 Dec;36(6):889-95. doi: 10.1002/ana.410360614. Ann Neurol. 1994. PMID: 7998776

5

Comparisons between SPECT and quantitative EEG measures of cortical impairment in mild to moderate Alzheimer's disease.

Montplaisir J, Petit D, McNamara D, Gauthier S. Montplaisir J, et al. Among authors: gauthier s. Eur Neurol. 1996;36(4):197-200. doi: 10.1159/000117247. Eur Neurol. 1996. PMID: 8814420 Clinical Trial.

6

Functional disability in Alzheimer's disease.

Gauthier S, Gélinas I, Gauthier L. Gauthier S, et al. Among authors: gauthier l. Int Psychogeriatr. 1997;9 Suppl 1:163-5. doi: 10.1017/s1041610297004857. Int Psychogeriatr. 1997. PMID: 9447439

7

Clinical trials and therapy.

Gauthier S. Gauthier S. Curr Opin Neurol. 1998 Oct;11(5):435-8. doi: 10.1097/00019052-199810000-00004. Curr Opin Neurol. 1998. PMID: 9847991 Review.

8

Do we have a treatment for Alzheimer disease? Yes.

Gauthier S. Gauthier S. Arch Neurol. 1999 Jun;56(6):738-9. doi: 10.1001/archneur.56.6.738. Arch Neurol. 1999. PMID: 10369316 Review. No abstract available.

9

Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living.

Gélinas I, Gauthier S, Cyrus PA. Gélinas I, et al. Among authors: gauthier s. J Geriatr Psychiatry Neurol. 2000 Spring;13(1):9-16. doi: 10.1177/089198870001300102. J Geriatr Psychiatry Neurol. 2000. PMID: 10753002 Clinical Trial.

10

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.

Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E; Donepezil MSAD Study Investigators Group. Feldman H, et al. Among authors: gauthier s. Neurology. 2001 Aug 28;57(4):613-20. doi: 10.1212/wnl.57.4.613. Neurology. 2001. PMID: 11524468 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,129 results

Search Page

Filters